TAK-778 | Interleukin Related interleukin-related.com

Product Name :
TAK-778

Search keywords :
TAK-778

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Osteogenesis stimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Takeda

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Fractures, Bone

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-c-Jun(Ser63) Antibody
LAMP2a Antibody
MSR1 Antibody: MSR1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 50 kDa, targeting to MSR1. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts